Manulife (Manufacturers Life Insurance)’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.1M | Buy |
441,957
+16,717
| +4% | +$1.21M | 0.03% | 485 |
|
|
2026
Q1 | $29M | Sell |
425,240
-1,266
| -0.3% | -$89.6K | 0.02% | 506 |
|
|
2025
Q4 | $32.4M | Buy |
426,506
+1,507
| +0.4% | +$110K | 0.03% | 507 |
|
|
2025
Q3 | $26.1M | Buy |
424,999
+383,307
| +919% | +$20M | 0.02% | 565 |
|
|
2025
Q2 | $2.04M | Sell |
41,692
-1,468
| -3% | -$69.7K | ﹤0.01% | 1493 |
|
|
2025
Q1 | $2.2M | Buy |
43,160
+1,586
| +4% | +$79.1K | ﹤0.01% | 1450 |
|
|
2024
Q4 | $1.88M | Sell |
41,574
-1,418
| -3% | -$60.7K | ﹤0.01% | 1595 |
|
|
2024
Q3 | $1.6M | Sell |
42,992
-804
| -2% | -$26.9K | ﹤0.01% | 1669 |
|
|
2024
Q2 | $1.34M | Buy |
43,796
+2,660
| +6% | +$86.2K | ﹤0.01% | 1685 |
|
|
2024
Q1 | $1.2M | Sell |
41,136
-24,518
| -37% | -$687K | ﹤0.01% | 1760 |
|
|
2023
Q4 | $1.81M | Sell |
65,654
-163
| -0.2% | -$3.73K | ﹤0.01% | 1501 |
|
|
2023
Q3 | $1.47M | Sell |
65,817
-15,788
| -19% | -$587K | ﹤0.01% | 1538 |
|
|
2023
Q2 | $3.32M | Buy |
81,605
+24,614
| +43% | +$1.2M | ﹤0.01% | 1259 |
|
|
2023
Q1 | $2.76M | Buy |
56,991
+10,001
| +21% | +$457K | ﹤0.01% | 1310 |
|
|
2022
Q4 | $1.77M | Sell |
46,990
-3,549
| -7% | -$148K | ﹤0.01% | 1419 |
|
|
2022
Q3 | $2.54M | Sell |
50,539
-497
| -1% | -$24.4K | ﹤0.01% | 1321 |
|
|
2022
Q2 | $2.05M | Sell |
51,036
-435
| -0.8% | -$15.3K | ﹤0.01% | 1415 |
|
|
2022
Q1 | $1.92M | Buy |
51,471
+15,969
| +45% | +$615K | ﹤0.01% | 1521 |
|
|
2021
Q4 | $1.42M | Sell |
35,502
-194
| -0.5% | -$7.42K | ﹤0.01% | 1634 |
|
|
2021
Q3 | $1.33M | Sell |
35,696
-3,379
| -9% | -$139K | ﹤0.01% | 1668 |
|
|
2021
Q2 | $1.65M | Buy |
39,075
+4,223
| +12% | +$181K | ﹤0.01% | 1691 |
|
|
2021
Q1 | $1.65M | Sell |
34,852
-2,127
| -6% | -$126K | ﹤0.01% | 1631 |
|
|
2020
Q4 | $2.26M | Buy |
36,979
+1,299
| +4% | +$76.6K | ﹤0.01% | 1483 |
|
|
2020
Q3 | $1.67M | Sell |
35,680
-1,029
| -3% | -$50.7K | ﹤0.01% | 1471 |
|
|
2020
Q2 | $1.86M | Sell |
36,709
-1,520
| -4% | -$74.7K | ﹤0.01% | 1419 |
|
|
2020
Q1 | $1.71M | Buy |
38,229
+3,893
| +11% | +$196K | ﹤0.01% | 1350 |
|
|
2019
Q4 | $1.65M | Sell |
34,336
-1,053
| -3% | -$44.7K | ﹤0.01% | 1461 |
|
|
2019
Q3 | $1.23M | Buy |
35,389
+167
| +0.5% | +$7.27K | ﹤0.01% | 1555 |
|
|
2019
Q2 | $1.58M | Buy |
35,222
+1,813
| +5% | +$71.6K | ﹤0.01% | 1451 |
|
|
2019
Q1 | $1.26M | Buy |
33,409
+5,416
| +19% | +$182K | ﹤0.01% | 1581 |
|
|
2018
Q4 | $961K | Sell |
27,993
-1,437
| -5% | -$51.7K | ﹤0.01% | 1599 |
|
|
2018
Q3 | $1.38M | Sell |
29,430
-4,011
| -12% | -$166K | ﹤0.01% | 1606 |
|
|
2018
Q2 | $1.13M | Buy |
33,441
+3,475
| +12% | +$108K | ﹤0.01% | 1792 |
|
|
2018
Q1 | $811K | Sell |
29,966
-942
| -3% | -$23.9K | ﹤0.01% | 1974 |
|
|
2017
Q4 | $516K | Buy |
30,908
+36
| +0.1% | +$609 | ﹤0.01% | 2301 |
|
|
2017
Q3 | $618K | Buy |
30,872
+4,681
| +18% | +$91.6K | ﹤0.01% | 2121 |
|
|
2017
Q2 | $479K | Sell |
26,191
-248
| -0.9% | -$3.34K | ﹤0.01% | 2327 |
|
|
2017
Q1 | $260K | Sell |
26,439
-9,514
| -26% | -$115K | ﹤0.01% | 2647 |
|
|
2016
Q4 | $392K | Sell |
35,953
-681
| -2% | -$7.14K | ﹤0.01% | 2277 |
|
|
2016
Q3 | $514K | Sell |
36,634
-537
| -1% | -$4.37K | ﹤0.01% | 2071 |
|
|
2016
Q2 | $261K | Buy |
37,171
+2,321
| +7% | +$17K | ﹤0.01% | 2506 |
|
|
2016
Q1 | $212K | Buy |
34,850
+281
| +0.8% | +$4.88K | ﹤0.01% | 2556 |
|
|
2015
Q4 | $1.12M | Buy |
34,569
+8,422
| +32% | +$248K | ﹤0.01% | 1571 |
|
|
2015
Q3 | $698K | Buy |
26,147
+652
| +3% | +$27.9K | ﹤0.01% | 1786 |
|
|
2015
Q2 | $1.23M | Buy |
25,495
+5,229
| +26% | +$305K | ﹤0.01% | 1577 |
|
|
2015
Q1 | $1.23M | Buy |
20,266
+785
| +4% | +$47.9K | ﹤0.01% | 1565 |
|
|
2014
Q4 | $1.01M | Buy |
19,481
+737
| +4% | +$32.4K | ﹤0.01% | 1579 |
|
|
2014
Q3 | $825K | Buy |
18,744
+147
| +0.8% | +$4.6K | ﹤0.01% | 1677 |
|
|
2014
Q2 | $487K | Buy |
18,597
+2,346
| +14% | +$50.2K | ﹤0.01% | 2057 |
|
|
2014
Q1 | $425K | Buy |
16,251
+8,514
| +110% | +$229K | ﹤0.01% | 2192 |
|
|
2013
Q4 | $131K | Buy |
7,737
+7,574
| +4,647% | +$133K | ﹤0.01% | 2959 |
|
|
2013
Q3 | $3K | Buy |
+163
| New | +$2.83K | ﹤0.01% | 3470 |
|
Other funds holding PTCT
RI
JT
Manulife (Manufacturers Life Insurance)'s PTCT Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) increased its PTC Therapeutics (PTCT) stake by 3.9% in Q2 2026, buying an estimated $1.21M and bringing the position to 441,957 shares worth $36.1M. The position accounts for 0.03% of the portfolio, ranked #485.
Manulife (Manufacturers Life Insurance) first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 441,957 shares of PTC Therapeutics worth $36.1M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) bought 16,717 PTC Therapeutics shares in Q2 2026, an estimated $1.21M.
- PTC Therapeutics made up 0.03% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #485 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.